Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism BACE1 inhibitors(Beta-secretase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC34H44N10O10 |
InChIKeyIOHHQCLTBSFSAT-WBAQKLHDSA-N |
CAS Registry753030-13-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | JP | 03 Jan 2005 |